Skip to content

RDLNetworkEcosystem

Sign in Get started

© 2026 Raw Data Library. All rights reserved.

About FAQ Privacy Terms Contact

AMD3100/CXCR4 Inhibitor — De Clercq Erik (2015) | RDL Network

Home
Publications
AMD3100/CXCR4 Inhibitor

Shared by

AMD3100/CXCR4 Inhibitor

Article 2015 en

Related publications

The anti-HIV activity of the CXCR4 inhibitor AMD3100 is independent of the CXCR4/HIV coreceptor level

Katrien Princen, Sigrid Hatse, Kurt Vermeire, Gary Bridger, Renato T. Skerlj, De Clercq Erik, Dominique Schols

AMD3100, a small molecule inhibitor of HIV-1 entry via the CXCR4 co-receptor

G A Donzella,

Authors

De Clercq Erik
KU Leuven

Abstract

1 min read

status: Published

Discussion(0)

Sign in to like and join the discussion.

No comments yet. Be the first to comment.

Publication Info

DOI: 10.3389/fimmu.2015.00276
Year: 2015
Published: —
Language: en

Article Details

Volume: 6
Link Of The Paper: https://doi.org/10.3389/fimmu.2015.00276

Timeline

Created:June 19, 2026

Dominique Schols,

Steven Lin,

José A. Esté,

Kirsten Nagashima,

Paul J. Maddon,

Graham P. Allaway,

Thomas P. Sakmar,

Geoffrey Henson,

De Clercq Erik,

John P. Moore

Potential Clinical Applications of the CXCR4 Antagonist Bicyclam AMD3100

Chemokine receptor inhibition by AMD3100 is strictly confined to CXCR4

Sigrid Hatse, Katrien Princen, Gary Bridger, De Clercq Erik, Dominique Schols

Mutations at the CXCR4 interaction sites for AMD3100 influence anti‐CXCR4 antibody binding and HIV‐1 entry

Sigrid Hatse, Katrien Princen, Kurt Vermeire, Lars‐Ole Gerlach, Mette M. Rosenkilde, Thue W. Schwartz, Gary Bridger, De Clercq Erik, Dominique Schols